DEUTSCHE BANK AG\ - SPDR SER TR ownership

SPDR SER TR's ticker is TFI and the CUSIP is 78468R721. A total of 291 filers reported holding SPDR SER TR in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SPDR SER TR
ValueSharesWeighting
Q3 2023$590,474
-5.3%
13,5120.0%0.00%
Q2 2023$623,714
-1.4%
13,5120.0%0.00%
Q1 2023$632,632
-22.1%
13,512
-24.1%
0.00%
Q4 2022$811,899
-47.7%
17,797
-49.5%
0.00%
-100.0%
Q3 2022$1,551,000
-4.1%
35,2620.0%0.00%0.0%
Q2 2022$1,618,000
-12.8%
35,262
-9.0%
0.00%0.0%
Q1 2022$1,856,000
-8.6%
38,762
-1.2%
0.00%0.0%
Q4 2021$2,030,000
-1.6%
39,250
-1.8%
0.00%0.0%
Q3 2021$2,062,000
-11.4%
39,986
-10.5%
0.00%0.0%
Q2 2021$2,328,000
+12.7%
44,670
+11.7%
0.00%0.0%
Q1 2021$2,066,000
-14.7%
39,986
-13.3%
0.00%0.0%
Q4 2020$2,421,000
+3.9%
46,123
+2.8%
0.00%
-50.0%
Q3 2020$2,331,000
-4.5%
44,872
-5.0%
0.00%0.0%
Q2 2020$2,441,000
+16.3%
47,252
+12.7%
0.00%0.0%
Q1 2020$2,098,000
+1.7%
41,939
+2.8%
0.00%
+100.0%
Q4 2019$2,063,000
+4.9%
40,801
+5.1%
0.00%0.0%
Q3 2019$1,967,000
-17.9%
38,839
-18.8%
0.00%0.0%
Q2 2019$2,397,000
+12.0%
47,842
+10.1%
0.00%0.0%
Q1 2019$2,140,000
-7.3%
43,440
-9.6%
0.00%
-50.0%
Q4 2018$2,309,000
+94.7%
48,045
+92.3%
0.00%
Q3 2018$1,186,000
-18.6%
24,980
-17.7%
0.00%
Q2 2018$1,457,000
-6.8%
30,356
-6.9%
0.00%
-100.0%
Q1 2018$1,564,00032,5910.00%
Other shareholders
SPDR SER TR shareholders Q4 2020
NameSharesValueWeighting ↓
Buttonwood Financial Group, LLC 192,542$8,288,9376.05%
CLIFTONLARSONALLEN WEALTH ADVISORS, LLC 3,218,514$140,649,0753.94%
Sterling Financial Group, Inc. 103,210$4,510,2552.83%
Revolve Wealth Partners, LLC 267,640$11,695,8612.69%
Braun-Bostich & Associates Inc. 32,951$1,439,9432.69%
Aquire Wealth Advisors, LLC 125,027$5,463,6802.28%
ROBINSON CAPITAL MANAGEMENT, LLC 107,000$4,644,8702.07%
Goodman Advisory Group, LLC 125,799$5,497,3982.05%
One Capital Management, LLC 824,484$36,029,9501.60%
JFS WEALTH ADVISORS, LLC 371,449$16,232,3331.53%
View complete list of SPDR SER TR shareholders